U.S. Medical Equipment Stock News

In the past quarter, People Incorporated reported second‑quarter 2026 sales of US$436.74 million, with net income rising to US$506.85 million and earnings per share more than doubling year on year, alongside guidance for full‑year 2026 operating income of US$15 million to US$80 million. The company also continued reshaping its portfolio by completing a multi‑year share buyback totaling 18.7% of shares and agreeing to sell a non‑core fund stake for about US$189 million in cash, while...

Tower Semiconductor (TSEM) has attracted fresh attention after reporting record Q2 2026 revenue of US$460.08 million and net income of US$90.77 million, along with guidance for a new revenue high in Q3. See our latest analysis for Tower Semiconductor. Tower Semiconductor’s latest results have arrived after a period of sharp gains and some recent volatility, with a 1-year total shareholder return above 300% and year to date share price return of 73.44% suggesting strong momentum despite a...

Q2 earnings event puts Black Hills in focus Black Hills (BKH) is in the spotlight after reporting second quarter 2026 results on August 5, with higher net income and earnings per share from continuing operations compared with a year earlier. See our latest analysis for Black Hills. Despite Black Hills reporting higher net income and earnings per share for the quarter and affirming its quarterly dividend on July 28, the stock shows mixed momentum, with a 1-year total shareholder return of...

Cisco Systems has delivered very strong share price gains over the past five years, and at around US$121.50 the stock now screens as roughly in line with its intrinsic value estimate from a Discounted Cash Flow (DCF) model rather than clearly cheap or clearly expensive. Cisco Systems has returned about 150.1% over the past 5 years, which puts extra focus on whether the current valuation still leaves enough room for long term returns. Expectations around demand for AI infrastructure and...

Datavault AI (DVLT) is back on investor screens after amending its agreement with DataMeds AI to expand PharmacyChain licensing into broader healthcare and wellness, while restructuring its stake into common shares categorized as revenue. See our latest analysis for Datavault AI. Despite the expanded DataMeds AI agreement and recent management and investor events, Datavault AI’s short term momentum remains weak, with the share price down 24% in the last day and 72% year to date, alongside...

Why Hartford Insurance Group stock is in focus now Hartford Insurance Group (HIG) is back on investor radar after reporting second quarter 2026 results, updating its share repurchase activity and outlining a new buyback authorization alongside an acquisition in employee benefits. See our latest analysis for Hartford Insurance Group. Hartford Insurance Group’s latest earnings, buyback update and the planned acquisition of Equitable’s Employee Benefits business come after a period where the...

Bel Fuse stock cooled off into the close, slipping about 3% after a strong run earlier in the week, even as Q2 numbers pointed to margin strength rather than strain. The market marked the shares down. The earnings print told a different story. The real headline was profitability. Revenue came in at about US$210.7m with adjusted earnings before interest, tax, depreciation and amortization of US$48.9m and a gross margin just under 40%. For a power electronics and connectivity manufacturer, that...

ExxonMobil Holdings (XOM) is back in focus after reporting second quarter 2026 earnings tied to high oil prices, record refining margins, and an unusually sharp political backlash over wartime fuel profits. See our latest analysis for ExxonMobil Holdings. ExxonMobil Holdings' share price has pulled back slightly in the last week after the earnings release and political criticism. However, the year to date share price return of 23.63% and 1 year total shareholder return of 46.90% still point...

Construction Partners (ROAD) has drawn investor attention after recent share price moves, with the stock down about 3% over the past month and about 20% over the past 3 months. See our latest analysis for Construction Partners. Over a longer window, Construction Partners has combined a 12.46% 1 year total shareholder return with a 3 year total shareholder return of 213.92%. However, recent 90 day share price performance has faded after earlier strength. If this kind of move has you thinking...

Douglas Emmett stock slipped 1.3% today to about US$11.80, which is a muted move for a real estate investment trust that just posted another quarter of unprofitable earnings. The emotional drag is clear. Investors are fixating on the reported loss per share and the weight of higher interest costs, while the core real estate engine tells a more balanced story. The real action sits in funds from operations and cash generation. Funds From Operations held in the mid US$70m range in the quarter...

Rigel Pharmaceuticals came into this print with a stock that had already run hard over the past three months, then added another 4.6% to close at US$40.48 after the Q2 release. That jump sits on a simple headline. The company stayed profitable and lifted Q2 total revenue to US$78.7m while keeping net income at US$17.3m, even as cash slipped to US$95.3m. For a biotech that trades on promise as much as on product, this quarter was about proving the earnings are real enough to matter. Is Rigel...

In the second quarter of 2026, Cleveland-Cliffs Inc. reported sales of US$5,226 million and a net loss of US$145 million, both improved from a year earlier, while executing no additional share repurchases under its April 2024 buyback program. The results show sales growth alongside a smaller loss per share, indicating that cost and operational measures are narrowing the company’s losses even as it pauses incremental buybacks. With quarterly losses narrowing and sales higher, we’ll now...

In August 2026, Viavi Solutions Inc. reported fourth-quarter fiscal 2026 results showing sales of US$443.1 million and net income of US$32.7 million, and issued first-quarter fiscal 2027 net revenue guidance of US$450 million to US$460 million. While the full year still showed a net loss of US$30.4 million, the latest quarter’s stronger profitability and continued outperformance versus earnings estimates highlighted improving operational momentum. We’ll now examine how Viavi’s stronger...

Callaway Golf stock slipped about 2% today, even though the quarter just delivered one of the cleanest margin stories the company has put up in a while. Revenue for Q2 came in at US$612.2m, but the real headline was profit quality, with net income from ongoing operations at US$75.8m and management highlighting a sharp lift in gross margin. Investors came into this print after a strong 90 day run in the stock, so expectations were high. The reaction suggests nerves about sustainability, not...

Why this earnings report matters for Global Net Lease investors Global Net Lease (GNL) released second quarter and half year 2026 results on 5 August, reporting lower sales than a year earlier, but a shift to quarterly net income and a sharply smaller half year loss. See our latest analysis for Global Net Lease. Global Net Lease’s recent results arrive after a mixed price run, with the share price down 4.22% over the past month and 5.48% over the past quarter, while the 1 year total...

EVgo stock dropped about 12% to US$1.53 into Thursday, extending a weak 30 day stretch and setting a low bar for this earnings print. The market focused on the red ink, with Q2 2026 delivering a basic loss per share of US$0.15 and net loss of US$20.8m. Looking past the near term pain presents a different picture. Charging network revenue was US$61m, and management is guiding to US$400m to US$430m of revenue for 2026 with an adjusted EBITDA loss that could narrow by year end. This quarter...

On August 3, 2026, Helus Pharma appointed Michael Halstead as Chief Executive Officer, bringing 25 years of biopharma experience and a record of leading major drug launches, large-scale integrations and multi billion-dollar M&A transactions. Halstead’s history of guiding companies from clinical development to full commercial operations may signal a shift in how Helus Pharma approaches growth, partnerships and capital allocation. We’ll now explore how bringing in a CEO with extensive...

PROCEPT BioRobotics stock jumped 5.8% to US$19.34 after its Q2 earnings, even though the broader three month stretch for the shares has been weak. The move reflects a simple story. Investors are rewarding evidence that the growth engine is still firing while withholding any credit for profits that are not yet there. The headline this quarter is revenue. PROCEPT BioRobotics reported US$94.5m in Q2 sales and management kept full year revenue guidance of US$390m to US$410m intact. That...

Why Applied Industrial Technologies Stock Is Back in Focus Recent analysis highlighting improving earnings prospects and a favorable ranking has pushed Applied Industrial Technologies (AIT) back onto investors’ radar, as the stock continues to outperform Industrial Products sector peers so far this year. See our latest analysis for Applied Industrial Technologies. At a latest share price of US$358.14, Applied Industrial Technologies has posted a 30-day share price return of 9.01% and a year...

Insulet stock just endured a 20% one day hit, sliding from about US$166.82 to roughly US$133.26, even as the latest quarter landed with solid headline strength. The company delivered Q2 revenue of US$801.7 million and basic earnings per share of US$1.37, supported by a trailing P/E of 24.6x that sits below the broader medical equipment peer group. The clash is clear: the tape is trading fear around the new type 2 diabetes rollout and customer retention, while the numbers show a business that...

Alphabet (GOOGL) is back in focus after CEO Sundar Pichai reshaped Google DeepMind’s leadership, moving Nobel Prize recipient Demis Hassabis into a new chief scientist role while he also continues in the chair position. See our latest analysis for Alphabet. Alphabet’s share price fell around 4% in the latest session after the DeepMind reshuffle. The stock still carries a 15% year to date share price return and a very strong 1 year total shareholder return of 85.36%. This suggests momentum has...

PTC (PTC) has just rolled out new product lifecycle and application lifecycle tools, including Arena Connect and fresh Codebeamer and Pure Variants releases. These AI supported updates aim to improve workflow automation, integration, and compliance. See our latest analysis for PTC. Despite a steady run of product updates and refreshed guidance through July and early August, PTC’s recent share price performance has been mixed, with a 30 day share price return of 11.56% but a year to date share...

In the second quarter of 2026, United Fire Group, Inc. reported revenue of US$383.73 million and net income of US$33.37 million, both higher than a year earlier, with diluted EPS from continuing operations rising to US$1.29. Across the first half of 2026, the company’s higher revenue and earnings versus the prior year highlight improved profitability from its core insurance operations. With earnings from continuing operations improving meaningfully, we’ll now assess how this stronger...

Clear Secure came into this print with a premium P/E, a soft three month share performance and a reputation as a high growth airport subscription story. The stock is up about 1.3% today, which is a muted response given the headline. Q2 delivered record free cash flow of US$189 million and adjusted EBITDA margin of 36.4%, finally clearing the 35% target management set back at the IPO. For a security and identity platform that investors often treat like a travel tollbooth, this quarter is...